Assistant Professor, Medicine, University of Maryland School of Medicine

Hematology

Dr. Margit N. Horiba, MD


Dr. Margit N. Horiba works in the field of Hematology. She went to medical school at Tulane University School of Medicine. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Margit N. Horiba, MD is also a published physician. She has 2 publication published. The most recent publication is: Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin. She accepts Medicare payments and is listed with Medicare.gov.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1821130550
NPPES Provider LastName   HORIBA
NPPES Provider FirstName   MARGIT
NPPES Provider ZIPCode   212011544
NPPES Provider State   MD
Specialty Description   Hematology
Total Claim Count   220.0
Distinct Opioid Count   1.0
Opioid Claim Count   30.0
Percent Opioid Claims   13.64

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1821130550
Last Name Of The Provider HORIBA
First Name Of The Provider MARGIT
View All

Similar Doctors


Dr. Timothy F. Burns, MD
Dr. Daniel A. Laheru, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Arnob Banerjee, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Ephraim J. Fuchs, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Charles A. Padgett, MD
Dr. Saul Yanovich, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Ivan M. Borrello, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Christopher J. Melani, MD
This Doctor is OpenDoctor Recommended.
Dr. James G. Herman, MD
This Doctor is OpenDoctor Recommended.
Dr. Seble Chekol, MD
Dr. Lois K. Kamugisha, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog